This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
AstraZeneca (AZN.L) – Smashed forecasts for Q2 sales and earnings, demonstrating resilience after seeing off a $118bn takeover approach from rival drugmaker Pfizer. Sales in the Q1 rose 4% to $6.45bn ($6.29bn expected). Raises full year guidance. Closing price 4357.00p. (Reuters)
BG Group (BG..L) – 11% rise in Q2 operating profit, driven by higher LNG volumes and higher realised prices in Asia and South America. Expects production at the lower end of its forecast of 590,000-630,000 (boepd) for the year. Closing Price 1179.00p (Reuters)
BT Group (BT.A.L) – Strong demand for fibre broadband and television helped report Q1 results in line with forecasts, and to keep its outlook unchanged. Reported revenue up 0.5% on an underlying basis to £4.4b. Core earnings were flat at £1.4bn, both in line with forecasts. Closing price 387.90p. (Reuters)
Centrica (CNA.L) – Posted a 35% fall in operating profits during the first half of the year as mild weather in Britain led to reduced demand and extreme weather in North America increased costs for the company. Closing Price 314.20p (Reuters)
Kazakhmys (KAZ.L) – Copper output fell in the first half of this year as it reduced output in higher-cost areas to protect margins and conserve cash. Closing Price 340.40p (Reuters)
Lloyds (LLOY.L) – Reported a 32% increase in underlying H1 profit, helping it absorb an increase in the cost of compensating customers miss-sold loan insurance. Reported an underlying profit of £3.8bn, benefiting from an increased margin and improving economic conditions. Closing price 76.41p. (Reuters)
Rolls-Royce (RR.L) – On track to meet forecasts for the year, as it reported an expected 20% drop in H1 profit due to shrinking government defence spending and currency headwinds. Pretax profit of £644m (£607m expected). Closing Price 1055.00p (Reuters)
Royal Dutch Shell (RDSA/B.L) – Q2 earnings were $5.1bn compared with $2.4bn for same quarter a year ago. Q2 dividend of $0.47 per ordinary share, an increase of 4% compared with Q2 2013. Closing prices 2382.00p/2489.00p. (Reuters)
Thomas Cook (TCG.L) – Reported a recovery in quarterly earnings and said it was confident its transformation plan was on track. posted earnings before interest and taxes (EBIT) of £33m, a big improvement on the £1m it made in the same period last year, helped by the timing of Easter. Closing price 121.90p. (Reuters)
TSB Bank (TSB.L) – Underlying profit H1 fell 17% from a year ago after it incurred far higher costs after spinning out and listing on its own last month. Pretax profit was £78.6m, (£94.6m last year). Closing price 282.00p. (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Antofagasta | ANTO.L | -4.56% | -0.35% | -4.85% |
| Barclays | BARC.L | 4.24% | 5.37% | 2.30% |
| British American Tobacco | BATS.L | -1.23% | -0.22% | -1.33% |
| Compass | CPG.L | -2.48% | 0.10% | -3.03% |
| ITV | ITV.L | -0.24% | 2.61% | -2.98% |
| Moneysupermarket.com | MONY.L | 1.87% | 4.78% | 0.33% |
| Taylor Wimpey | TW.L | -1.75% | 3.14% | -1.83% |
| Travis Perkins | TPK.L | 2.67% | 4.13% | 0.00% |
| Tullow Oil | TLW.L | -1.11% | 0.27% | -1.90% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research